2023
Anti-Müllerian Hormone Level Decline in Patients Undergoing Hysterectomy With and Without Oophorectomy Compared With Natural Menopause
Santoro N, Flyckt R, Davis A, Finkelstein J, Crawford S, Sun F, Derby C, Morrison A, Sluss P, Zhang H. Anti-Müllerian Hormone Level Decline in Patients Undergoing Hysterectomy With and Without Oophorectomy Compared With Natural Menopause. Obstetrics And Gynecology 2023, 141: 331-340. PMID: 36649324, PMCID: PMC9858351, DOI: 10.1097/aog.0000000000005049.Peer-Reviewed Original ResearchConceptsFinal menstrual periodAnti-Müllerian hormone levelsAMH levelsNatural menopauseHormone levelsUndetectable AMH levelsCommunity-based studyOvarian conservationOvarian reserveAMH measurementOvarian failureMenstrual periodSurgery dateHysterectomyLinear mixed modelingMenopauseSurvival analysisPatientsImmediate reductionMixed modelingWomenOvariesSimilar patternRapid declineBSO
2014
A novel staging model to classify oesophageal squamous cell carcinoma patients in China
Tan H, Zhang H, Xie J, Chen B, Wen C, Guo X, Zhao Q, Wu Z, Shen J, Wu J, Xu X, Li E, Xu L, Wang X. A novel staging model to classify oesophageal squamous cell carcinoma patients in China. British Journal Of Cancer 2014, 110: 2109-2115. PMID: 24569468, PMCID: PMC3992487, DOI: 10.1038/bjc.2014.101.Peer-Reviewed Original ResearchConceptsESCC patientsClinical variablesStaging systemOesophageal squamous cell carcinoma patientsSurvival analysisSquamous cell carcinoma patientsOesophageal squamous cell carcinomaKaplan-Meier survival analysisCell carcinoma patientsPotential prognostic factorsTNM staging systemSquamous cell carcinomaMetastasis (TNM) staging systemOesophageal carcinomaPrognostic factorsCarcinoma patientsCell carcinomaSame hospitalESCC prognosisPredominant subtypeRisk scoreIndependent cohortPatientsSurvival rateStaging model